Cargando…
Evaluation of a Novel Oncolytic Adenovirus Silencing SYVN1
Oncolytic adenoviruses are promising new anticancer agents. To realize their full anticancer potential, they are being engineered to express therapeutic payloads. Tumor suppressor p53 function contributes to oncolytic adenovirus activity. Many cancer cells carry an intact TP53 gene but express p53 i...
Autores principales: | Vermeulen, Christie, Brachtlova, Tereza, Tol, Nikki, van der Meulen-Muileman, Ida H., Hodzic, Jasmina, van de Vrugt, Henri J., van Beusechem, Victor W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737683/ https://www.ncbi.nlm.nih.gov/pubmed/36499754 http://dx.doi.org/10.3390/ijms232315430 |
Ejemplares similares
-
Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens
por: Brachtlova, Tereza, et al.
Publicado: (2018) -
Human Non-Small Cell Lung Cancer-Chicken Embryo Chorioallantoic Membrane Tumor Models for Experimental Cancer Treatments
por: Li, Jing, et al.
Publicado: (2023) -
Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format
por: Brachtlova, Tereza, et al.
Publicado: (2020) -
A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting
por: Hodzic, Jasmina, et al.
Publicado: (2015) -
A genome‐wide siRNA screen for regulators of tumor suppressor p53 activity in human non‐small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment
por: Siebring‐van Olst, Ellen, et al.
Publicado: (2017)